NEUROCAP NEUROCAP 1.5MM NC01-015/03

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a study,user facility report with the FDA on 2017-05-11 for NEUROCAP NEUROCAP 1.5MM NC01-015/03 manufactured by Polyganics Innovations Bv.

Event Text Entries

[74902876] Patient is participating in (b)(6) clinical study stop neuroma (clinicaltrials. Gov identifier: (b)(6)). Below an overview of sequence of events: on (b)(6) 2016 surgery. No complications or remarks. Neurocap 1. 5 mm implanted. Wk of (b)(6) 2016 surgeon indicates to polyganics representative that patient hit operation site on corner of night table; ae was most probably discovered when removing stitches at 10-day follow up. Ae was indicated by surgeon as non-device related, just an unfortunate event. On (b)(6) 2017 ae reported in ecrf regarding accident indicated "bumped operated hand on corner night table". Causality is marked "other". Date of onset is marked as (b)(6) 2017. The ae is graded mild, not related to the study procedure and not related to the study device. The action taken in resolving the ae was closing the wound with adhesive strips. On (b)(6) 2017 6-week follow up visit. The ae at the operational site is noted to be resolved without sequelae. Around this time the ae was also discussed informally with the surgeon by a polyganics representative. The ae was again noted to be an unfortunate event rather than device related. On (b)(6) 2017 3-month follow up. Seroma formation at the operational site, likely originating from the earlier ae but the latter was not confirmed in writing. On (b)(6) 2017 sae noted. Event onset reported to be (b)(6) 2017. Causality noted as "disease under study". Ongoing sae, which resulted in re-intervention in the week of (b)(6) (estimate, to be confirmed with surgeon). (remainder of) neurocap was removed, further actions in surgery unknown at time of this report. Surgeon indicated by (informal) email at inquiry after the patient's well being at (b)(6) 2017 that the patient was healing alright after immobilisation. Surgeon's response per email: despite antibiotics, persistent swelling causing reintervention. Removed material was tested by the lab: negative growth, so no bacterial infection. The patient is now recovering. Product not returned as it is degraded.
Patient Sequence No: 1, Text Type: N, H10


[74902877] Severe seroma formation at location dissolving neurocap.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004504732-2017-00002
MDR Report Key6559665
Report SourceSTUDY,USER FACILITY
Date Received2017-05-11
Date of Report2017-05-11
Date of Event2017-03-01
Date Mfgr Received2017-04-11
Date Added to Maude2017-05-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. BETTY IJMKER
Manufacturer StreetROZENBURGLAAN 15A
Manufacturer CityGRONINGEN, GRONINGEN 9727DL
Manufacturer CountryNL
Manufacturer Postal9727DL
Manufacturer Phone05886598
Manufacturer G1POLYGANICS INNOVATIONS BV
Manufacturer StreetROZENBURGLAAN 15A
Manufacturer CityGRONINGEN, GRONINGEN 9727DL
Manufacturer CountryNL
Manufacturer Postal Code9727DL
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEUROCAP
Generic NameNERVE CUFF
Product CodeJXI
Date Received2017-05-11
Model NumberNEUROCAP 1.5MM
Catalog NumberNC01-015/03
Lot NumberNCA2016060811
Device Expiration Date2017-12-08
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerPOLYGANICS INNOVATIONS BV
Manufacturer AddressROZENBURGLAAN 15A GRONINGEN, GRONINGEN 9727DL NL 9727DL


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2017-05-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.